Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May-Jun;35(3):1327-1336.
doi: 10.21873/invivo.12385. Epub 2021 Apr 28.

Adhesion Molecules in Non-melanoma Skin Cancers: A Comprehensive Review

Affiliations
Review

Adhesion Molecules in Non-melanoma Skin Cancers: A Comprehensive Review

Joanna Pogorzelska-Dyrbus et al. In Vivo. 2021 May-Jun.

Abstract

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most frequently diagnosed cancers, generating significant medical and financial problems. Cutaneous carcinogenesis is a very complex process characterized by genetic and molecular alterations, and mediated by various proteins and pathways. Cell adhesion molecules (CAMs) are transmembrane proteins responsible for cell-to-cell and cell-to-extracellular matrix adhesion, engaged in all steps of tumor progression. Based on their structures they are divided into five major groups: cadherins, integrins, selectins, immunoglobulins and CD44 family. Cadherins, integrins and CD44 are the most studied in the context of non-melanoma skin cancers. The differences in expression of adhesion molecules may be related to the invasiveness of these tumors, through the loss of tissue integrity, neovascularization and alterations in intercellular signaling processes. In this article, each group of CAMs is briefly described and the present knowledge on their role in the development of non-melanoma skin cancers is summarized.

Keywords: Cell adhesion molecules; basal cell carcinoma; non-melanoma skin cancer; review; squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

The Authors declare that there are no conflicts of interest regarding the publication of this article.

Similar articles

Cited by

References

    1. Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D. Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017;7(2):1–6. doi: 10.5826/dpc.0702a01. - DOI - PMC - PubMed
    1. Lesiak A, Czuwara J, Kamińska-winciorek G, Kiprian D, Maj J, Owczarek W, Placek W, Rudnicka L, Rutkowski P, Sobjanek M, Sokołowska-wojdyło M, Szepietowski J, Zegarska B, Zegarski W. Basal cell carcinoma. Diagnostic and therapeutic recommendations of Polish dermatological society. Dermatology Review. 2019;106(2):107–126. doi: 10.5114/dr.2019.85572. - DOI
    1. Apalla Z, Nashan D, Weller RB, Castellsagué X. Skin cancer: Epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther (Heidelb) . 2017;7(Suppl 1):5–19. doi: 10.1007/s13555-016-0165-y. - DOI - PMC - PubMed
    1. Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014;810:120–140. doi: 10.1007/978-1-4939-0437-2_7. - DOI - PubMed
    1. Didona D, Paolino G, Bottoni U, Cantisani C. Non melanoma skin cancer pathogenesis overview. Biomedicines. 2018;6(1):6. doi: 10.3390/biomedicines6010006. - DOI - PMC - PubMed